The Novartis Innovation Prize: Assistive Tech for Multiple Sclerosis (MS) was launched in 2020 to promote solutions to mobility challenges faced by the MS community, and to increase awareness of the need for “outside-in” innovation that directly involves these communities from day one.
The panel for this event includes the winner of the prize, Professor Chas Bountra, a leader from the disability tech space, a leading patient advocate, the EU Commission, and the university’s Pro-Vice-Chancellor For Innovation. He is also a member of the management board for the BioEscalator.
Professor Bountra will be considering the future of innovation in healthcare in a post-COVID era, and how industry, policy, academia and entrepreneurs can work collaboratively together to shape this.
Professor Chas Bountra, Professor of Translational Medicine; Chief Scientist, Structural Genomics Consortium Oxford
Srin Madipalli, Global Accessibility Expert and Entrepreneur
Donna Walsh, Executive Director, European Federation of Neurological Associations
Maayan Ziv, Founder, CEO, AccessNow
Pēteris Zilgalvis, Head of Digital Innovation and Blockchain
Vreni Schoenenberger, Global Head of Public Affairs, Neuroscience, Novartis
No registration needed